Open access
Aug 2025
Development of an RNA aptamer as a therapeutic agent for synucleinopathies
The findings indicate that RNA aptamers, such as 1R6, may represent promising therapeutic candidates for synucleinopathies, thus opening new avenues in the treatment of these diseases.
K. Murakami, Thi Hong Van Nguyen, L. Tsuda et al.
· bioRxiv · 1 citation